Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu-Wen Tien

Showing results (111-120 of 130) with videos related to

Pageof 13
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|March 20, 2016
PET/MRI in pancreatic and periampullary cancer: correlating diffusion-weighted imaging, MR spectroscopy and glucose metabolic activity with clinical stage and prognosisBang-Bin Chen, Yu-Wen Tien, Ming-Chu Chang, et al.
The Journal of Experimental Medicine|March 4, 2015
Targeting IL-17B-IL-17RB signaling with an anti-IL-17RB antibody blocks pancreatic cancer metastasis by silencing multiple chemokinesHeng-Hsiung Wu, Wendy W Hwang-Verslues, Wen-Hsin Lee, et al.
Cancer Immunology, Immunotherapy : CII|August 10, 2021
The role of S100A9 in the interaction between pancreatic ductal adenocarcinoma cells and stromal cellsPin-Jui Kung, Ting-Yu Lai, Jerry Cao, et al.
Cancer Chemotherapy and Pharmacology|March 26, 2009
Phase II study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of 5-fluorouracil/leucovorin (GOFL) in advanced pancreatic cancerHui-Ju Ch'ang, Chin-Lun Huang, Hsiu-Po Wang, et al.
American Journal of Cancer Research|January 22, 2019
Cellular 5-hydroxylmethylcytosine content determines tumorigenic potential and prognosis of pancreatic ductal adenocarcinomaYi-Lng Chen, Chun-Mei Hu, Jeh-Ting Hsu, et al.
Journal of the American Medical Directors Association|November 15, 2018
Three Nurse-administered Protocols Reduce Nutritional Decline and Frailty in Older Gastrointestinal Surgery Patients: A Cluster Randomized TrialCheryl Chia-Hui Chen, Yi-Ting Yang, I-Rue Lai, et al.
British Journal of Cancer|February 10, 2024
Unraveling the impact of cancer-associated fibroblasts on hypovascular pancreatic neuroendocrine tumorsTing-Yu Lai, Tsai-Chen Chiang, Chih-Yuan Lee, et al.
Clinical Chemistry|February 11, 2016
Clinical Significance of Circulating Tumor Microemboli as a Prognostic Marker in Patients with Pancreatic Ductal AdenocarcinomaMing-Chu Chang, Yu-Ting Chang, Jia-Yang Chen, et al.
Medicine|April 22, 2016
A High Circulating Tumor Cell Count in Portal Vein Predicts Liver Metastasis From Periampullary or Pancreatic Cancer: A High Portal Venous CTC Count Predicts Liver MetastasesYu Wen Tien, Hsun-Chuan Kuo, Be-Ing Ho, et al.
JAMA Surgery|May 25, 2017
Effect of a Modified Hospital Elder Life Program on Delirium and Length of Hospital Stay in Patients Undergoing Abdominal Surgery: A Cluster Randomized Clinical TrialCheryl Chia-Hui Chen, Hsiu-Ching Li, Jin-Tung Liang, et al.
Pageof 13

Showing results (111-120 of 130) with videos related to

Sort By:
Pageof 13
European Journal of Nuclear Medicine and Molecular Imaging|March 20, 2016
PET/MRI in pancreatic and periampullary cancer: correlating diffusion-weighted imaging, MR spectroscopy and glucose metabolic activity with clinical stage and prognosisBang-Bin Chen, Yu-Wen Tien, Ming-Chu Chang, et al.
The Journal of Experimental Medicine|March 4, 2015
Targeting IL-17B-IL-17RB signaling with an anti-IL-17RB antibody blocks pancreatic cancer metastasis by silencing multiple chemokinesHeng-Hsiung Wu, Wendy W Hwang-Verslues, Wen-Hsin Lee, et al.
Cancer Immunology, Immunotherapy : CII|August 10, 2021
The role of S100A9 in the interaction between pancreatic ductal adenocarcinoma cells and stromal cellsPin-Jui Kung, Ting-Yu Lai, Jerry Cao, et al.
Cancer Chemotherapy and Pharmacology|March 26, 2009
Phase II study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of 5-fluorouracil/leucovorin (GOFL) in advanced pancreatic cancerHui-Ju Ch'ang, Chin-Lun Huang, Hsiu-Po Wang, et al.
American Journal of Cancer Research|January 22, 2019
Cellular 5-hydroxylmethylcytosine content determines tumorigenic potential and prognosis of pancreatic ductal adenocarcinomaYi-Lng Chen, Chun-Mei Hu, Jeh-Ting Hsu, et al.
Journal of the American Medical Directors Association|November 15, 2018
Three Nurse-administered Protocols Reduce Nutritional Decline and Frailty in Older Gastrointestinal Surgery Patients: A Cluster Randomized TrialCheryl Chia-Hui Chen, Yi-Ting Yang, I-Rue Lai, et al.
British Journal of Cancer|February 10, 2024
Unraveling the impact of cancer-associated fibroblasts on hypovascular pancreatic neuroendocrine tumorsTing-Yu Lai, Tsai-Chen Chiang, Chih-Yuan Lee, et al.
Clinical Chemistry|February 11, 2016
Clinical Significance of Circulating Tumor Microemboli as a Prognostic Marker in Patients with Pancreatic Ductal AdenocarcinomaMing-Chu Chang, Yu-Ting Chang, Jia-Yang Chen, et al.
Medicine|April 22, 2016
A High Circulating Tumor Cell Count in Portal Vein Predicts Liver Metastasis From Periampullary or Pancreatic Cancer: A High Portal Venous CTC Count Predicts Liver MetastasesYu Wen Tien, Hsun-Chuan Kuo, Be-Ing Ho, et al.
JAMA Surgery|May 25, 2017
Effect of a Modified Hospital Elder Life Program on Delirium and Length of Hospital Stay in Patients Undergoing Abdominal Surgery: A Cluster Randomized Clinical TrialCheryl Chia-Hui Chen, Hsiu-Ching Li, Jin-Tung Liang, et al.
Pageof 13